We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Non-Invasive Ultrasound Imaging Device Diagnoses Risk of Chronic Kidney Disease

By HospiMedica International staff writers
Posted on 27 Mar 2024

Managing chronic kidney disease (CKD) efficiently is imperative for public health, as it represents a progressive condition affecting 10% of the worldwide population. More...

The path from CKD to end-stage renal disease (ESRD) often involves renal fibrosis, making early detection and continuous monitoring critical for effective treatment and prognosis. Correctly identifying patients at elevated risk for advancing renal fibrosis remains a complex task in clinical settings. Researchers have now created a computer-based diagnostic tool that combines ultrasound (US) imagery with specific clinical indicators to evaluate the risk of moderate-to-severe renal fibrosis progression in individuals with CKD.

By leveraging advanced health technology, this innovative diagnostic tool Smart-CKD (S-CKD) developed by researchers from the Hong Kong Polytechnic University (PolyU, Hong Kong) can improve CKD management and patient monitoring. S-CKD integrates three essential clinical parameters: the patient's age, the ultrasonic renal length, and the end-diastolic velocity in the interlobar renal artery, all obtainable through regular medical follow-ups. Utilizing machine learning, S-CKD achieves a diagnostic accuracy of 80%. Available as an online web-based tool and an offline document, S-CKD offers a convenient, real-time, non-invasive method for clinicians to assess renal fibrosis risk, thus guiding therapeutic decisions, patient counseling, and follow-up scheduling.

Additionally, the research group has developed a machine learning-based model using 2-D shear wave elastography (SWE) combined with CKD clinical data to assess renal fibrosis. Despite the advancements in ultrasound elastography for diagnosing renal fibrosis, the technique's effectiveness heavily relies on the operator's skill, posing challenges in settings with limited resources. S-CKD aims to facilitate the application of ultrasound elastography in various clinical environments, enabling accurate, low-cost risk stratification using data easily extracted from medical records and standard imaging assessments.

Further, the team has introduced an ultrasound radiomics analysis, progressing from clinical data to in-depth ultrasound image examination. Radiomics, a cutting-edge field, extracts a multitude of imaging features invisible to the human eye from medical images, building models for non-invasive renal fibrosis evaluations. This radiomics method combines ultrasound imaging with clinical data to create a diagnostic model visualized through a web-based calculator. Although current models require manual input from medical professionals, future efforts will explore artificial intelligence, including deep learning, to develop a fully automated diagnostic system.

“The implementation of S-CKD holds the potential to assist healthcare practitioners in tailoring medical judgments and optimizing post-treatment protocols for CKD patients,” said Prof. Michael Tin Cheung YING, Associate Head and Professor of Department of Health Technology and Informatics at PolyU. “By utilizing non-invasive medical imaging results and basic demographic data, this tool offers a cost-effective solution for guiding patient management, thereby contributing to notable clinical advantages.”

Related Links:
PolyU 


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: FDA clearance of multiFiltratePRO and approval of dedicated solutions expand continuous kidney replacement therapy options for U.S. patients with acute kidney injury. (Photo courtesy of Fresenius Medical Care)

U.S. Launch Expands Kidney Replacement Therapy Options With Integrated Anticoagulation

Critically ill patients with acute kidney injury often require continuous kidney replacement therapy in intensive care units. During these extracorporeal treatments, careful anticoagulation management... Read more

Surgical Techniques

view channel
Image: The LUCID prototype, which combines a miniature ultrasound device with a fluid-delivery tube, an osmotic pump and custom electronics. A coin provides a sense of scale. The system is designed to deliver substances directly into brain tissue and uses ultrasound to help them spread. (Photo courtesy of MIT)

Implantable Ultrasound Device Enhances Local Drug Delivery in Glioblastoma

Glioblastoma is an aggressive brain tumor that frequently recurs after surgery. Although surgeons can remove visible tumor tissue, residual cancer cells may remain in surrounding brain tissue and contribute... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.